Pathology of Gastric Intestinal Metaplasia: Clinical Implications
暂无分享,去创建一个
M. Piazuelo | P. Correa | K. Wilson | M Blanca Piazuelo | Pelayo Correa | Keith T Wilson | Blanca M. Piazuelo
[1] K. Ozasa,et al. Helicobacter pylori Infection and Gastric Cancer (A Nested Case-Control Study in a Rural Area of Japan) , 1997, Digestive Diseases and Sciences.
[2] N. Yoshimura,et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer , 2004, International journal of cancer.
[3] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[4] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.
[5] R. Peek,et al. Helicobacter infection and gastric neoplasia , 2006, The Journal of pathology.
[6] K. Miki,et al. Using serum pepsinogens wisely in a clinical practice , 2007, Journal of digestive diseases.
[7] E. Fontham,et al. Association of Interleukin-1β Gene Polymorphisms with Precancerous Gastric Lesions in African Americans and Caucasians , 2006, The American Journal of Gastroenterology.
[8] M. Redston,et al. Morphologic Features are Useful in Distinguishing Barrett Esophagus From Carditis With Intestinal Metaplasia , 2007, The American journal of surgical pathology.
[9] A. Teixeira,et al. Mucins as key molecules for the classification of intestinal metaplasia of the stomach , 2002, Virchows Archiv.
[10] N. Wright,et al. Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[11] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[12] F. Chan,et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication , 2004, Gut.
[13] M. Sobrinho-Simões,et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. , 1999, Cancer research.
[14] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[15] T. Hirota,et al. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. , 1980, Journal of the National Cancer Institute.
[16] M. Filipe,et al. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material. , 1986, Human pathology.
[17] P. Correa,et al. Sulphomucins favour adhesion of Helicobacter pylori to metaplastic gastric mucosa. , 1999, Journal of clinical pathology.
[18] D. Faigel,et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. , 2006, Gastrointestinal endoscopy.
[19] M. Rugge,et al. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1993, Endoscopy.
[20] H. Nielsen,et al. »Small Intestinal Type« and »Colonic Type« Intestinal Metaplasia of The Human Stomach, and Their Relationship to the Histogenetic Types of Gastric Adenocarcinoma , 1978, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[21] N. Muñoz,et al. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia , 1994, International journal of cancer.
[22] E. Kuipers,et al. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. , 2009, Gastrointestinal endoscopy.
[23] Wai K. Leung,et al. Intestinal metaplasia and gastric carcinogenesis , 2002 .
[24] W. Chey,et al. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection , 2007, The American Journal of Gastroenterology.
[25] K. Araki,et al. Serum Pepsinogen Levels, Helicobacter pylori CagA Status, and Cytokine Gene Polymorphisms Associated with Gastric Premalignant Lesions in Costa Rica , 2007, Cancer Epidemiology Biomarkers & Prevention.
[26] N. Muñoz,et al. Age and Severity of Mucosal Lesions Influence the Performance of Serologic Markers in Helicobacter pylori–Associated Gastroduodenal Pathologies , 2008, Cancer Epidemiology Biomarkers & Prevention.
[27] M. Fennerty,et al. Gastric intestinal metaplasia on routine endoscopic biopsy. , 2003, Gastroenterology.
[28] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[29] P. Correa,et al. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. , 1970, Journal of the National Cancer Institute.
[30] D. McGee,et al. Gastric intestinal metaplasia in ethnic groups in the southwestern United States. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] M. Gail,et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. , 2006, Journal of the National Cancer Institute.
[32] W. You,et al. Epidemiology of precancerous gastric lesions , 1993, Journal of gastroenterology and hepatology.
[33] T. Rokkas,et al. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. , 1991, Gut.
[34] E. Fontham,et al. Long term follow up of patients treated for Helicobacter pylori infection , 2005, Gut.
[35] Ali Ms. Letter: Geriatrics is medicine. , 1974, The Lancet.
[36] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[37] Charles Wiggins,et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. , 2007, Cancer.
[38] A. Jemal,et al. Global Cancer Statistics , 2011 .
[39] F. Di Mario,et al. Non-invasive tests in gastric diseases. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[40] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[41] A. Lilienfeld,et al. MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1976, The Lancet.
[42] Xiaocheng Wu,et al. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences , 2007, Cancer Causes & Control.
[43] P. Malfertheiner,et al. OLGA staging for gastritis: a tutorial. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[44] Amitabh Srivastava,et al. Gastric preneoplastic lesions and epithelial dysplasia. , 2007, Gastroenterology clinics of North America.
[45] K. Miki. Gastric cancer screening using the serum pepsinogen test method , 2002, Gastric Cancer.
[46] K. Heilmann,et al. Loss of differentiation in intestinal metaplasia in cancerous stomachs. A comparative morphologic study. , 1979, Pathology, research and practice.
[47] E. Kuipers,et al. Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn? , 2009, The American Journal of Gastroenterology.
[48] J. Sung,et al. Review article: intestinal metaplasia and gastric carcinogenesis. , 2002, Alimentary pharmacology & therapeutics.
[49] J. Fraumeni,et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. , 1992, Journal of the National Cancer Institute.
[50] J. Jass,et al. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma , 1981, The Histochemical Journal.
[51] M. Gail,et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.
[52] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[53] Nayoung Kim,et al. Progression of Atrophic Gastritis and Intestinal Metaplasia Drives Helicobacter pylori Out of the Gastric Mucosa , 2006, Digestive Diseases and Sciences.
[54] F. Mégraud,et al. Helicobacter pylori infection and gastric cancer. , 2006, European journal of cancer.
[55] M. Cattaruzza,et al. Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection , 2005, Alimentary pharmacology & therapeutics.
[56] G. Friedman,et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. , 1997, Gut.
[57] M. Piazuelo,et al. Phenotypic differences between esophageal and gastric intestinal metaplasia , 2004, Modern Pathology.
[58] Ming-Shiang Wu,et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. , 2009, Gastroenterology.
[59] M. Gail,et al. Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2001, Journal of the National Cancer Institute.
[60] D. Graham,et al. Topographic patterns of intestinal metaplasia and gastric cancer , 2000, American Journal of Gastroenterology.
[61] L. Brown,et al. Epidemiologic trends in esophageal and gastric cancer in the United States. , 2002, Surgical oncology clinics of North America.
[62] J. Goldblum,et al. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa , 2002, American Journal of Gastroenterology.
[63] J. Rotter,et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. , 1982, Gastroenterology.
[64] J. Watari,et al. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[65] S. Vollset,et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status , 2007, Gut.
[66] E. Fontham,et al. Diet and chronic atrophic gastritis: a case-control study. , 1986, Journal of the National Cancer Institute.
[67] D. Karamanolis,et al. Premalignant lesions and conditions for gastric adenocarcinoma: diagnosis, management and surveillance guidelines. , 2003, Hepato-gastroenterology.